Dr. Schechter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 W Woolbright Rd
Boynton Beach, FL 33426Phone+1 561-737-5500Fax+1 561-737-7055
Education & Training
- University of Texas Health Science Center at HoustonResidency, Ophthalmology, 1992 - 1993
- SUNY Downstate Health Sciences UniversityResidency, Ophthalmology, 1989 - 1992
- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1988 - 1989
- State University of New York Downstate Medical Center College of MedicineClass of 1988
Certifications & Licensure
- FL State Medical License 1992 - 2026
- TX State Medical License 1992 - 1993
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
- Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase Start of enrollment: 2007 Aug 01
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsOcular infections caused by Providencia rettgeriAaleya F. Koreishi, Barry A. Schechter, Carol L. Karp
Ophthalmology. 2006-08-01 - 38 citationsA Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye diseaseJoseph Tauber, Barry A Schechter, Jason Bacharach, Melissa M Toyos, Robert Smyth-Medina
Clinical Ophthalmology. 2018-10-02 - 71 citationsRegression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.Barry A. Schechter, Amilia Schrier, Robert S. Nagler, Edward F. Smith, Gabriel E. Velasquez
Cornea. 2002-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: